Exchange: NASDAQ·Updated 07:30 PM EDT
ELVN logo

ELVN Enliven Therapeutics Inc

$59.32
$0.33
(0.55%)
Today
Closed $59.32
$0.00
(0.00%)
After Hours
EarningsNov 11
Mkt Cap$4.35B
Vol1.11M

About ELVN

Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ELVN-001and HER2 Program: ELVN-002. The company was founded by Samuel S. Kintz, Joseph P. Lyssikatos, and Anish Patel on June 1, 2019 and is headquartered in Boulder, CO.
49

Neutral Sentiment

How do you feel about ELVN?

Advertisement|Remove ads.